Skip to main content

Table 2 RE-AIM Evaluation of Perinatal Addiction Education

From: Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol

Dimension and questions addressed

Data sources

Methods

Outcome/Process measures

Reach

 To what extent did perinatal addiction education reach the providers treating pregnant women with OUD in Your Counties?

Department of Professional Licensing

Identify all healthcare providers in the community licensed to potentially treat pregnant women with OUD

Number of community providers included in the study/ total number of community providers working with pregnant women with OUD

 To what extent did perinatal addiction education reach the pregnant women with OUD within the healthcare system in Your Counties?

Local healthcare and social service agencies

Electronic medical records; health department records

Number of patient participants/ total number of pregnant women with opioid misuse in Your Counties during the study duration

Efficacy

 How effective was the provider training and support?

Community providers

Questionnaires assessing skills, knowledge and satisfaction

Mixed method surveys regarding provider experience and skillset

 How effective were perinatal addiction education services in improving care for pregnant women with OUD?

Healthcare and social service records; patient participants

Compare data regarding illicit substance use, MOUD continuity, opioid poisoning occurrences, physical and mental health, and social service involvement; questionnaires to assess patient perception

Medical codes; standardized comprehensive wellness measurement instruments; qualitative surveys

Adoption

 To what extent are community providers using perinatal addiction education practices when treating patients with perinatal OUD?

Community providers; local healthcare agencies

Questionnaires assessing provider practices and attitudes; electronic medical records

Mixed methods surveys regarding provider practices; frequency of MOUD provision, NOWS treatment and SBIRT by participating community providers

 To what extent are patients utilizing resources made available through the perinatal addiction education program?

Partnering agencies (e.g. EUWH, Four Corners Behavioral Health); medical records; pharmacy records

Interviews with partner agencies; electronic medical record and pharmacy record evaluation

Utilization of care management and resources made available through this project; number of MOUD prescriptions filled; presence of BUP in urinalysis via medical record

Implementation

 What were the barriers and facilitators of high quality care?

Community providers

Questionnaires and focus groups

Perceptions of and feedback regarding the implementation kickoff event, as well as ongoing training and support provided via the implementation of perinatal addiction education

Maintenance

 Will the perinatal addiction education practices be maintained over time in Your Counties?

Community providers; healthcare administrators

Interviews and questionnaires with community providers and healthcare administrators regarding provider practices and policies

Questionnaire regarding how integrated perinatal addiction education practices are into standard treatment of pregnant women with OUD and what policies exist to support them

  1. OUD Opioid Use Disorder, MOUD Medication for Opioid Use Disorder, NOWS  Neonatal Opioid Withdrawal Syndrome, SBIRT Screening, Brief Intervention, and Referral to Treatment; BUP Buprenorphine